Delayed
Hong Kong S.E.
04:08:03 2024-03-28 EDT
|
5-day change
|
1st Jan Change
|
0.13
HKD
|
+5.69%
|
|
-.--%
|
-17.20%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
540.1
|
505.3
|
252.6
|
186.4
|
261.4
|
287.5
|
Enterprise Value (EV)
1 |
724.8
|
619.6
|
437.3
|
406.2
|
280.5
|
524.7
|
P/E ratio
|
-7.35
x
|
-135
x
|
-4.14
x
|
-1.95
x
|
-2.66
x
|
-2.93
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.35
x
|
1.34
x
|
0.69
x
|
0.53
x
|
0.72
x
|
0.84
x
|
EV / Revenue
|
1.81
x
|
1.64
x
|
1.19
x
|
1.15
x
|
0.77
x
|
1.53
x
|
EV / EBITDA
|
-16.5
x
|
51.5
x
|
-7.04
x
|
-6.9
x
|
-3.36
x
|
-7.81
x
|
EV / FCF
|
-3.98
x
|
-4.61
x
|
-
|
-13.6
x
|
-5.36
x
|
-81.5
x
|
FCF Yield
|
-25.1%
|
-21.7%
|
-
|
-7.38%
|
-18.7%
|
-1.23%
|
Price to Book
|
1.22
x
|
1.14
x
|
0.76
x
|
0.68
x
|
1.08
x
|
2.09
x
|
Nbr of stocks (in thousands)
|
871,178
|
871,178
|
871,178
|
871,178
|
1,306,767
|
1,306,767
|
Reference price
2 |
0.6200
|
0.5800
|
0.2900
|
0.2140
|
0.2000
|
0.2200
|
Announcement Date
|
11/13/17
|
11/13/18
|
5/15/20
|
4/28/21
|
4/28/22
|
4/28/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
400.5
|
377.2
|
367.7
|
354.2
|
362.5
|
343.5
|
EBITDA
1 |
-43.85
|
12.03
|
-62.12
|
-58.91
|
-83.42
|
-67.17
|
EBIT
1 |
-61.59
|
-11.67
|
-86.44
|
-73.41
|
-103.9
|
-80.7
|
Operating Margin
|
-15.38%
|
-3.09%
|
-23.51%
|
-20.73%
|
-28.67%
|
-23.49%
|
Earnings before Tax (EBT)
1 |
-74.1
|
15.49
|
-58.66
|
-94.99
|
-92.79
|
-96.81
|
Net income
1 |
-72.94
|
-3.756
|
-61
|
-95.82
|
-84.9
|
-98.06
|
Net margin
|
-18.21%
|
-1%
|
-16.59%
|
-27.05%
|
-23.42%
|
-28.54%
|
EPS
2 |
-0.0843
|
-0.004311
|
-0.0700
|
-0.1100
|
-0.0752
|
-0.0750
|
Free Cash Flow
1 |
-182.3
|
-134.6
|
-
|
-29.98
|
-52.34
|
-6.435
|
FCF margin
|
-45.51%
|
-35.68%
|
-
|
-8.46%
|
-14.44%
|
-1.87%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/13/17
|
11/13/18
|
5/15/20
|
4/28/21
|
4/28/22
|
4/28/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
185
|
114
|
185
|
220
|
19.2
|
237
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-4.212
x
|
9.509
x
|
-2.973
x
|
-3.731
x
|
-0.2301
x
|
-3.532
x
|
Free Cash Flow
1 |
-182
|
-135
|
-
|
-30
|
-52.3
|
-6.44
|
ROE (net income / shareholders' equity)
|
-17.3%
|
-0.97%
|
-
|
-31.2%
|
-33%
|
-52.3%
|
ROA (Net income/ Total Assets)
|
-5.06%
|
-0.78%
|
-
|
-5.77%
|
-8.25%
|
-7.05%
|
Assets
1 |
1,442
|
481.3
|
-
|
1,661
|
1,029
|
1,390
|
Book Value Per Share
2 |
0.5100
|
0.5100
|
0.3800
|
0.3200
|
0.1900
|
0.1100
|
Cash Flow per Share
2 |
0.1200
|
0.2200
|
0.1100
|
0.0400
|
0.0500
|
0.0200
|
Capex
1 |
169
|
28.9
|
20.6
|
21.7
|
10.4
|
5.35
|
Capex / Sales
|
42.27%
|
7.66%
|
5.59%
|
6.11%
|
2.88%
|
1.56%
|
Announcement Date
|
11/13/17
|
11/13/18
|
5/15/20
|
4/28/21
|
4/28/22
|
4/28/23
|
|
1st Jan change
|
Capi.
|
---|
| -17.20% | 32.63M | | +2.94% | 103B | | -11.86% | 59.25B | | +72.86% | 47.15B | | +11.16% | 37.09B | | +0.74% | 31.09B | | +4.74% | 18.82B | | +14.69% | 16.97B | | +9.34% | 13.67B | | -3.67% | 12.77B |
Other Commodity Chemicals
|